Management of Encephalitis with Multiple MRI Lesions
Begin intravenous acyclovir 10 mg/kg every 8 hours immediately upon suspicion of encephalitis with multiple brain lesions, without waiting for diagnostic confirmation, as delayed treatment beyond 4 days increases mortality from 8% to 28%. 1, 2
Immediate Empiric Treatment
- Start IV acyclovir within 6 hours of admission for any patient with suspected encephalitis, regardless of imaging findings, as HSV encephalitis is the most common treatable cause (25-40% of sporadic encephalitis cases) and early treatment is critical for survival. 3, 1, 2
- Administer acyclovir at 10 mg/kg IV every 8 hours for adults and adolescents (20 mg/kg every 8 hours for children), adjusting for renal impairment. 1, 2
- Continue empiric antibacterial coverage until bacterial infection is excluded by CSF analysis. 3
- Treatment duration should be 14-21 days for confirmed HSV encephalitis. 1, 2
Diagnostic Work-Up (Performed Concurrently with Treatment)
Neuroimaging Priority
- MRI with and without contrast is the imaging modality of choice, with approximately 90% sensitivity within 48 hours compared to only 25% sensitivity for CT. 1, 2
- Look for characteristic patterns:
- HSV encephalitis: Bilateral temporal lobe T2/FLAIR hyperintensities (present in >90% of cases), gyral edema, and involvement of cingulate gyrus. 3, 1, 2
- Autoimmune encephalitis: Discrete hippocampal high signal with associated swelling (60% of VGKC-complex cases), may be bilateral or unilateral. 3
- Other viral etiologies: Japanese B encephalitis affects thalamus/basal ganglia; enterovirus affects brainstem; VZV causes ischemic/hemorrhagic infarcts. 1
- If MRI is unavailable, perform CT to exclude structural causes of raised intracranial pressure, but do not rely on CT to rule out encephalitis due to poor sensitivity. 1, 2
Lumbar Puncture and CSF Analysis
- Perform lumbar puncture urgently (after imaging if concern for mass effect) with the following studies: 3, 1
- HSV-1, HSV-2, and VZV PCR (sensitivity/specificity >95% when performed days 2-10 of illness). 2
- Cell count with differential, protein, glucose, Gram stain, bacterial culture.
- Opening pressure measurement.
- Oligoclonal bands if autoimmune encephalitis suspected.
- Consider enterovirus, parechovirus, CMV, HHV-6/7 PCR in immunocompromised patients. 2
- A single negative HSV PCR does not rule out HSE, especially if obtained <72 hours after symptom onset—repeat LP in 24-48 hours if clinical suspicion remains high. 2
- Typical viral CSF shows elevated protein with normal glucose and lymphocytic pleocytosis. 1
Additional Diagnostic Studies
- Obtain neurology consultation immediately for all suspected encephalitis cases. 3
- Perform EEG to detect periodic lateralizing epileptiform discharges (PLEDs) in temporal regions, present in ~80% of HSV encephalitis cases. 1, 2
- Check serum autoimmune encephalitis panel (VGKC-complex, NMDA receptor antibodies) if subacute presentation, hyponatremia, orofacial dyskinesia, choreoathetosis, or faciobrachial dystonic seizures present. 3
- Screen for malignancy in confirmed antibody-mediated encephalitis (thymoma, small cell lung cancer). 3
- Blood tests: B12, HIV, rapid plasma reagin, ANA, Ro/La, TSH, aquaporin-4 IgG, cortisol, ACTH. 3
Management Based on Etiology
Confirmed or Suspected HSV Encephalitis
- Continue IV acyclovir 10 mg/kg every 8 hours for 14-21 days. 1, 2
- Monitor renal function closely and maintain adequate hydration to prevent acyclovir-induced crystalluria and obstructive nephropathy. 2
- Even with treatment, mortality remains 25-28% at 18 months, and 20-60% of survivors develop neurological sequelae. 2
Autoimmune/Antibody-Mediated Encephalitis
- Once bacterial and viral infections are excluded, initiate immunosuppression: 3
- For VGKC-complex antibody encephalitis: High-dose oral steroids (0.5 mg/kg/day) with antibody levels normalizing in 3-6 months, then taper over 12 months. 3
- If limited improvement with steroids/IVIG, consider rituximab or plasmapheresis in consultation with neurology. 3
- Remove any identified tumor (thymoma, small cell lung cancer). 3
Immune Checkpoint Inhibitor-Related Encephalitis
- Permanently discontinue the checkpoint inhibitor for grade 3-4 toxicity. 3
- Admit patient and initiate methylprednisolone 1 g daily for 3 days followed by oral corticosteroid taper. 3
- Consider IVIG 2 g/kg over 5 days for severe or progressive symptoms. 3
Critical Pitfalls to Avoid
- Never delay acyclovir while awaiting PCR or imaging results—this is the single most important factor affecting mortality and morbidity. 1, 2
- Do not discontinue acyclovir based on a single negative CSF PCR, especially if obtained early (<72 hours) or if clinical suspicion remains high. 2
- Do not use CT as the sole imaging modality to exclude encephalitis—its 25% sensitivity will miss most cases. 1, 2
- Do not start corticosteroids before excluding infectious causes, as this may worsen viral or bacterial encephalitis. 3
- In patients with multiple lesions, consider that this may represent either severe HSV encephalitis with extensive involvement, autoimmune encephalitis, or post-infectious ADEM—maintain broad differential until etiology confirmed. 3, 4, 5
Special Populations
- Immunocompromised patients: Expand PCR testing to include CMV, HHV-6/7, HIV; consider ganciclovir, foscarnet, or cidofovir for CMV encephalitis; prolonged acyclovir treatment may be needed for HSV clearance. 3, 2
- Renal impairment/dialysis patients: Significantly reduce acyclovir dosing based on creatinine clearance and maintain hydration. 6